What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Surgery
Mark E. Molitch mainly investigates Internal medicine, Endocrinology, Diabetes mellitus, Kidney disease and Surgery.
His Internal medicine study frequently involves adjacent topics like Gastroenterology.
The concepts of his Endocrinology study are interwoven with issues in Guideline, Clinical trial and Dopamine agonist.
His research integrates issues of Disease and Blood pressure in his study of Diabetes mellitus.
The Kidney disease study combines topics in areas such as Microalbuminuria and Intensive care medicine.
The study incorporates disciplines such as Pituitary adenoma, Adenoma and Transsphenoidal surgery in addition to Prolactinoma.
His most cited work include:
- Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. (1102 citations)
- Nephropathy in diabetes. (827 citations)
- Acromegaly: An Endocrine Society Clinical Practice Guideline (820 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Diabetes mellitus, Surgery and Prolactin.
His work in Internal medicine is not limited to one particular discipline; it also encompasses Gastroenterology.
His Endocrinology study combines topics from a wide range of disciplines, such as Dopamine agonist and Urology.
His work carried out in the field of Diabetes mellitus brings together such families of science as Renal function, Kidney disease and Intensive care medicine.
His study looks at the relationship between Kidney disease and fields such as Nephropathy, as well as how they intersect with chemical problems.
His Prolactinoma research is multidisciplinary, incorporating perspectives in Pregnancy, Cabergoline and Adenoma.
He most often published in these fields:
- Internal medicine (65.75%)
- Endocrinology (48.28%)
- Diabetes mellitus (28.74%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (65.75%)
- Diabetes mellitus (28.74%)
- Acromegaly (13.10%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Diabetes mellitus, Acromegaly, Octreotide and Gastroenterology.
He works mostly in the field of Internal medicine, limiting it down to topics relating to Endocrinology and, in certain cases, Cushing's disease.
His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Kidney disease and Renal function.
The Renal function study which covers Urology that intersects with Creatinine.
His Acromegaly study combines topics from a wide range of disciplines, such as Adverse effect and Phases of clinical research.
His Octreotide research incorporates elements of Adult patients and Somatostatin receptor.
Between 2016 and 2021, his most popular works were:
- Diagnosis and Treatment of Pituitary Adenomas: A Review (294 citations)
- Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone (171 citations)
- Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. (146 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Surgery
His main research concerns Internal medicine, Diabetes mellitus, Renal function, Urology and Type 1 diabetes.
His Internal medicine research includes themes of Gastroenterology, Endocrinology and Cardiology.
His Endocrinology study integrates concerns from other disciplines, such as Disease management, Disease and Mass screening.
His work on Type 2 diabetes as part of general Diabetes mellitus study is frequently connected to Electronic data, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His research investigates the link between Renal function and topics such as Kidney disease that cross with problems in Glycemic.
The Type 1 diabetes study combines topics in areas such as Proportional hazards model and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
